share_log

Vanda Pharmaceuticals Sees FY21 Sales Guidance Of $270M-$300M Vs $279.4M Estimates

Benzinga Real-time News ·  Feb 11, 2021 05:03
Vanda Pharmaceuticals Sees FY21 Sales Guidance Of $270M-$300M Vs $279.4M Estimates
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment